A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer

NCT01076504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Extensive-Stage Small Cell Lung Cancer

Interventions

DRUG: Amrubicin
DRUG: Carboplatin
DRUG: Pegfilgrastim

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]